Latest News and Press Releases

REYKJAVIK, Iceland, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...

Delivered 4,612 vehicles1 and achieved total revenue of $356 million in first nine months of 2025.Gross margin improved to 8% in the third quarter, reflecting healthier inventory dynamics and...

New York, USA, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Global Wound Healing Devices Market Poised for Robust Growth at a CAGR of ~5% by 2032, Driven by Rising Chronic Wound Burden | DelveInsight The...

REYKJAVIK, Iceland and LONDON, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for...

Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að hliðstæðan við Simponi (golimumab) hefði hlotið markaðsleyfi á Evrópska efnhagssvæðinu. Samstarfsaðili Alvotech við markaðssetningu hliðstæðunnar í...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a...

Nashville, TN, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Finding the perfect soundtrack is now three times easier, thanks to a new expanded library at Soundstripe that includes a curated collection of...

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "HD Maps for Autonomous Driving Market by Service Type (Mapping & Localization, Update & Maintenance), Vehicle Type (PC & CV), Solution Type...

Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product and service revenue increased by 85%, to $237 million in the first nine...

Total revenues in the first nine months of the year were $420 million, a 24% increase from the same period last year Product and service revenue increased by 85%, to $237 million in the first nine...